Literature DB >> 18562759

Primary malignant mixed mullerian tumor of the uterus: findings on sonography, CT, and gadolinium-enhanced MRI.

Sze Yiun Teo1, Kemi T Babagbemi, Hope E Peters, Koenraad J Mortele.   

Abstract

OBJECTIVE: The purpose of our study was to evaluate the sonographic, contrast-enhanced CT, and gadolinium-enhanced MRI findings of primary malignant mixed müllerian tumors (MMMTs) of the uterus.
CONCLUSION: Uterine MMMT most commonly presents as an intracavitary mass with coexistent dilatation of the endometrial canal. Tumors tend to appear hyperechoic on sonography, heterogeneously hypodense and ill defined on contrast-enhanced CT, and heterogeneously hyperintense on T2-weighted MR images with signal abnormalities indicating subacute hemorrhage on T1-weighted MR images. Myometrial invasion is common and has a predilection for the uterine fundus.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18562759     DOI: 10.2214/AJR.07.3281

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  9 in total

1.  The essence of the Japan Radiological Society/Japanese College of Radiology Imaging Guideline.

Authors:  Yasuyuki Yamashita; Sadayuki Murayama; Masahiro Okada; Yoshiyuki Watanabe; Masako Kataoka; Yasushi Kaji; Keiko Imamura; Yasuo Takehara; Hiromitsu Hayashi; Kazuko Ohno; Kazuo Awai; Toshinori Hirai; Kazuyuki Kojima; Shuji Sakai; Naofumi Matsunaga; Takamichi Murakami; Kengo Yoshimitsu; Toshifumi Gabata; Kenji Matsuzaki; Eriko Tohno; Yasuhiro Kawahara; Takeo Nakayama; Shuichi Monzawa; Satoru Takahashi
Journal:  Jpn J Radiol       Date:  2016-01       Impact factor: 2.374

2.  A predictive diagnostic model using multiparametric MRI for differentiating uterine carcinosarcoma from carcinoma of the uterine corpus.

Authors:  Yuki Kamishima; Mitsuru Takeuchi; Tatsuya Kawai; Takatsune Kawaguchi; Ken Yamaguchi; Naoki Takahashi; Masato Ito; Toshinao Arakawa; Akiko Yamamoto; Kazushi Suzuki; Masaki Ogawa; Moe Takeuchi; Yuta Shibamoto
Journal:  Jpn J Radiol       Date:  2017-06-05       Impact factor: 2.374

3.  The reasonable timing of the adjuvant radiotherapy in the treatment of uterine carcinosarcoma according to the surgical intent: suggestion based on progression patterns.

Authors:  Jeong Il Yu; Doo Ho Choi; Seung Jae Huh; Won Park; Dongryul Oh; Duk Soo Bae
Journal:  Radiat Oncol J       Date:  2013-06-30

Review 4.  Imaging Features of Uncommon Gynecologic Cancers.

Authors:  Maura Miccò; Evis Sala; Yulia Lakhman; Hedvig Hricak; Hebert Alberto Vargas
Journal:  AJR Am J Roentgenol       Date:  2015-12       Impact factor: 3.959

5.  Uterine carcinosarcomas (malignant mixed müllerian tumours): a review with special emphasis on the controversies in management.

Authors:  Rani Kanthan; Jenna-Lynn Senger
Journal:  Obstet Gynecol Int       Date:  2011-10-05

6.  CT imaging of ovarian yolk sac tumor with emphasis on differential diagnosis.

Authors:  Yang-Kang Li; Yu Zheng; Jian-Bang Lin; Gui-Xiao Xu; Ai-Qun Cai; Xiu-Guo Zhou; Guo-Jun Zhang
Journal:  Sci Rep       Date:  2015-06-15       Impact factor: 4.379

7.  Unenhanced region on magnetic resonance imaging represents tumor progression in uterine carcinosarcoma.

Authors:  Ayami Inoue; Ken Yamaguchi; Yasuhisa Kurata; Ryusuke Murakami; Kaoru Abiko; Junzo Hamanishi; Eiji Kondoh; Tsukasa Baba; Aki Kido; Ikuo Konishi; Noriomi Matsumura
Journal:  J Gynecol Oncol       Date:  2017-06-01       Impact factor: 4.401

8.  Uterine Carcinosarcoma in a Young Female: Case Report and Literature Review.

Authors:  Noha N Soror; Daniel Woredekal; Lori Hemrock; Gary Gibson; Robert Bennett
Journal:  Cureus       Date:  2021-01-11

9.  Utility of magnetic resonance imaging for differentiating malignant mesenchymal tumors of the uterus from T2-weighted hyperintense leiomyomas.

Authors:  Koichiro Matsuura; Kaiji Inoue; Eri Hoshino; Masanori Yasuda; Kosei Hasegawa; Yoshitaka Okada; Yasutaka Baba; Eito Kozawa
Journal:  Jpn J Radiol       Date:  2021-11-09       Impact factor: 2.374

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.